Journal of Experimental & Clinical Cancer Research (Apr 2023)
Correction: Peglated-H1/pHGFK1 nanoparticles enhance anti-tumor effects of sorafenib by inhibition of drug-induced autophagy and stemness in renal cell carcinoma
Abstract
No abstracts available.